FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 13:37:36 2024-05-24 EDT | ||
| 1.49 EUR | +2.76% |
|
| Current month | -50.66% | ||
| 1 month | -51.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 1.49 | +2.76% |
| 24-05-23 | 1.45 | +6.62% |
| 24-05-22 | 1.36 | -1.45% |
| 24-05-21 | 1.38 | +1.47% |
| 24-05-20 | 1.36 | -0.73% |
Delayed Quote Deutsche Boerse AG
Last update May 24, 2024 at 01:37 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK9D10 |
| ISIN | DE000UK9D107 |
| Date issued | 2022-11-10 |
| Strike | 383.1 $ |
| Maturity | Unlimited |
| Parity | 46.37 : 1 |
| Emission price | 5.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.65 € |
|---|---|
| Lowest since issue | 1.08 € |
| Spread | 0.05 € |
| Spread % | 3.21% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
